Net Loss Per Share

6 Months Ended

Jun. 30, 2022

The numerators and denominators of the basic and diluted net loss per share are computed as follows (in thousands, except per share, unit and per unit data):



	Three Months Ended June 30,				Six Months Ended June 30,
Basic and diluted net loss per share	2022		2021		2022		2021
Numerator:
Net loss	$	(56,844)	$	(3,175)	$	(75,669)	$	(5,612)
Denominator:
Weighted average shares outstanding—basic and diluted	126,223,903		105,000,000		129,037,598		105,000,000
Basic and diluted net loss per Share	$	(0.45)	$	(0.03)	$	(0.59)	$	(0.05)

As of June 30, 2022, there were outstanding Stock Options to purchase 957,569 shares of common stock at a weighted-average exercise price of $8.18, outstanding private warrants and public warrants to convert to 319,893 shares and 12,005,879 shares, respectively, of common stock at a price of $11.50 per share, convertible notes to convert to 18,844,600 shares of common stock at a conversion price of $10.61, ESPP contributions for the option to acquire 477,280 shares of common stock, and outstanding restricted stock units and performance stock units representing the right to receive 3,035,461 shares and 150,000 shares of common stock, respectively. Because of the net loss incurred during the three and six months ended June 30, 2022, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded from loss per share calculations. There were no potentially dilutive instruments for the three and six months ended June 30, 2021.